Infectious Diseases in Critical Care Medicine

29. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003;51(suppl 3):
    iii13–iii21.


30. Moritz EM, Hergenrother PJ. Toxin-antitoxin systems are ubiquitous and plasmid-encoded in
    vancomycin-resistant enterococci. Proc Natl Acad Sci 2007;104(1):311–316.


31. Top J, Willems R, Bonten M. Emergence of CC17Enterococcus faecium: from commensal to hospital-
    adapted pathogen. FEMS Immunol Med Microbiol 2008;52(3):297–308.


32. McGeer AJ, Low DE. Vancomycin-resistant enterococci. Semin Respir Infect 2000;14(4):314–326.


33. Murray BE. Drug therapy: vancomycin-resistant enterococcal infections. N Engl J Med 2000;342(10):
    710–721.


34. Kreiswirth B, Kornblum J, Arbeit RD, et al. Evidence for a clonal origin of methicillin resistance in
    Staphylococcus aureus. Science 1993;259(1):227–230.


35. Musser JM, Kapur V. Clonal analysis of methicillin-resistantStaphylococcus aureusstrains from
    intercontinental sources: association of themecgene with divergent phylogenetic lineages implies
    dissemination by horizontal transfer and recombination. J Clin Microbiol 1992;30(8):2058–2063.


36. Mongkolrattanothai K, Boyle S, Kahana MD, et al. SevereStaphylococcus aureusinfections caused by
    clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin
    Infect Dis 2003;37(8):1050–1058.


37. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant
    Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections.
    Curr Opin Infect Dis 2003;16(2):103–124.


38. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of
    methicillin-resistantStaphylococcus aureus. Clin Infect Dis 2004;39(1):47–54.


39. Baba T, Takenchi F, Kuroda M, et al. Genome and virulence determinants of high virulence
    community-acquired MRSA. Lancet 2002;359:1819–1827.


40. Eguia JM, Chambers HF. Community-acquired methicillin-resistantStaphylococcus aureus: epidemi-
    ology and potential virulence factors. Curr Infect Dis Rep 2003;5:459–466.


41. Chaix C, Durand-Zaleski I, Alberti C, et al. Control of endemic methicillin-resistantStaphylococcus
    aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282(18):1745–1751.


42. Squier C, Rihs JD, Risa J, et al.Staphylococcus aureusrectal carriage and its association with infections
    in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol
    2002;23(9):495–501.


43. Marshall C, Harrington G, Wolfe R, et al. Acquisition of methicillin-resistantStaphylococcus aureusin
    a large intensive care unit. Infect Control Hosp Epidemiol 2003;24(5):322–326.


44. Cassone M, Campanile F, Pantosti A, et al. Identification of a variant “Rome clone” of methicillin-
    resistantStaphylococcus aureuswith decreased susceptibility to vancomycin, responsible for an
    outbreak in an intensive care unit. Microb Drug Resist 2004;10:43–49.


45. Thompson DS. Methicillin-resistantStaphylococcus aureusin a general intensive care unit. JR Soc Med
    2004;97:521–526.


46. Gastmeier P, Sohr D, Geffers C, et al. Mortality risk factors with nosocomialStaphylococcus aureus
    infections in intensive care units: results from the German Nosocomial Infection Surveillance System
    (KISS). Infection 2005;33(2):50–55.


47. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistantStaphylo-
    coccus aureusinfections from a neonatal intensive care unit. J Infect Dis 1995;171(3):614–624.


48. Andersen BM, Lindermann R, Bergh K, et al. Spread of methicillin-resistantStaphylococcus aureusin a
    neonatal intensive unit associated with understaffing, overcrowding and mixing of patients. J Hosp
    Infect 2002;50(1):18–24.


49. Nambiar S, Herwaldt LA, Singh N. Outbreak of invasive disease caused by methicillin-resistant
    Staphylococcus aureusin neonates and prevalence in the neonatal intensive care unit. Pediatr Crit
    Care Med 2003;4(2):220–226.


50. Isaacs D, Fraser S, Hogg G, et al.Staphylococcus aureusinfections in Australasian neonatal nurseries.
    Arch Dis Child Fetal Neonatal Ed 2004;89:F331–F335.


51. Saiman L, Cronquist A, Wu F, et al. An outbreak of methicillin-resistantStaphylococcus aureusin a
    neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24(5):317–321.


52. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant
    Staphylococcus aureusin Western Australia. J Hosp Infect 1993;25(2):97–108.


53. Maquire GP, Arthur AD, Boustead PJ, et al. Clinical experience and outcomes of community-
    acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian
    hospital. J Hosp Infect 198;38(4):273–281.


54. O’Brien FG, Pearman JW, Gracy M, et al. Community strain of methicillin-resistantStaphylococcus
    aureusinvolved in a hospital outbreak. J Clin Microbiol 1999;37(9):2858–2862.

MRSA/VRE Colonization and Infection in the Critical Care Unit 121